NorthWest Biotherapeutics Inc (NWBO)

[Extremist223]

So you are saying that LL had blinded pfs numbers for the whole trial and strongly predicted that no placebo would be left to progress by that date given historical comparisons.

I can see it being possible they didn't move forward for AA so that they can load up and regain % stake.

Correct me if I'm wrong, but what you were trying to do is look at the most recently enrolled placebo patients and calculate how many should be progression free by her presentation?

Can we get a little better proof it's close to zero?